[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100395157":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":29,"responsibleParty":133,"collaborators":10,"id":135,"slug":136,"hasResults":137,"nctId":138,"briefTitle":139,"officialTitle":139,"acronym":140,"eligibilityCriteria":141,"healthyVolunteers":137,"sex":142,"minAge":10,"maxAge":143,"enrollmentInfo":144,"targetDuration":10,"studyType":16,"phases":10,"briefSummary":147,"conditions":148,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":150,"lastUpdatePostDateStruct":151,"startDateStruct":154,"completionDateStruct":156,"leadSponsor":158,"locationsCount":159},{"fullName":5,"class":6},"French Africa Pediatric Oncology Group","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All children with Burkitt lymphoma and in 2 units the addition of Rituximab",null,"An amendment has been added to give 4 injections during induction treatments as in the study in adults, that is to say 1 injection on D1 and D6 of each induction treatment, COPM or COPADM depending on the risk group in two centers. It is an amendment of the therapeutic recommendations \"GFA LMB2019\" which are the basis, the other centers will continue with this GFALMB2019 protocol as is",[13],"Other: OBSERVATIONAL",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"OBSERVATIONAL","OBSERVAITON OF THE CAPACITY OF THE GROUP TO TREAT ACCORDING TO THE PROTOCOLE AND LOOK AT OUTCOME FOR STAGE I AND II DISEASE",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Chantal Ms BOUDA, Dr.","CONTACT","00(226)70 10 01 30","cgbouda@yahoo.fr",{"name":26,"role":22,"phone":27,"phoneExt":10,"email":28},"BRENDA MALLON, MSc PhD","0033142115411","brenda.mallon@gustaveroussy.fr",[30,46,59,74,88,103,118],{"facility":31,"status":32,"city":33,"state":10,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Hopital Yalgado Ouedraogo","RECRUITING","Ouagadougou","03 BP 7022","Burkina Faso","BF",{"type":38,"coordinates":39},"Point",[40,41],-1.53388,12.36566,{"lat":41,"lon":40},[44],{"name":45,"role":22,"phone":10,"phoneExt":10,"email":10},"BOUDA CHANTAL, DR",{"facility":47,"status":32,"city":48,"state":10,"zip":10,"country":49,"countryCode":10,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"CHU de Treichville à ABIDJAN","Abidjan","Côte d’Ivoire",{"type":38,"coordinates":51},[52,53],-4.00167,5.35444,{"lat":53,"lon":52},[56],{"name":57,"role":22,"phone":10,"phoneExt":10,"email":58},"Line Dr COUITCHERE, MD","line.couitchere@gfaop.org",{"facility":60,"status":32,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Cliniques Universitaires de Kinshasa","Kinshasa","Kinshasa City","BP 12 KIN XI","Democratic Republic of the Congo","CD",{"type":38,"coordinates":67},[68,69],15.31357,-4.32758,{"lat":69,"lon":68},[72],{"name":73,"role":22,"phone":10,"phoneExt":10,"email":10},"BUDIONGO Aléine, DR",{"facility":75,"status":32,"city":76,"state":10,"zip":77,"country":64,"countryCode":65,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"Cliniques Universitaires de Lubumbashi (CUL)","Lubumbashi","BP 1825",{"type":38,"coordinates":79},[80,81],27.47938,-11.66089,{"lat":81,"lon":80},[84],{"name":85,"role":22,"phone":86,"phoneExt":10,"email":87},"LUKAMBA Robert, DR","00(243) 814024633","robertlukamba@yahoo.fr",{"facility":89,"status":32,"city":90,"state":10,"zip":91,"country":92,"countryCode":93,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona","Antananarivo","BP 4150","Madagascar","MG",{"type":38,"coordinates":95},[96,97],47.53613,-18.91368,{"lat":97,"lon":96},[100],{"name":101,"role":22,"phone":102,"phoneExt":10,"email":10},"Mbolanirina RAKOTOMAHEFA, Dr","34 14 201 51",{"facility":104,"status":32,"city":105,"state":10,"zip":10,"country":106,"countryCode":107,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"CHU Gabriel Touré (HGT)","Bamako","Mali","ML",{"type":38,"coordinates":109},[110,111],-7.97522,12.60915,{"lat":111,"lon":110},[114],{"name":115,"role":22,"phone":116,"phoneExt":10,"email":117},"BOUBACAR TOGO, PROFESSEUR","+223 66 74 29 04","boubacar.togo@gfaop.org",{"facility":119,"status":32,"city":120,"state":10,"zip":121,"country":122,"countryCode":123,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"Hôpital Aristide Le Dantec","Dakar","BP 3001","Senegal","SN",{"type":38,"coordinates":125},[126,127],-17.44406,14.6937,{"lat":127,"lon":126},[130],{"name":131,"role":22,"phone":132,"phoneExt":10,"email":10},"Fatou-Binetou DIAGNE AKONDE, Dr","00(221)77 637 40 63",{"type":134,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100395157","recommendations-for-the-treatment-of-children-with-burkitts-lymphoma-100395157",false,"NCT04425421","Recommendations for the Treatment of Children With Burkitt's Lymphoma","GFALMB2019","Inclusion Criteria:\n\nClinical diagnosis of Burkitt's Lymphoma: all location. Diagnosis by cytology or histology. Not possible to follow all the treatment.\n\n\\-\n\nExclusion Criteria:\n\nNot a B Cell tumor. Child has been previously treated. Child has also another illness which would render the treatment incompatible. Parents refusal.","ALL","18 Years",{"count":145,"type":146},1000,"ESTIMATED","This is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP). The study hopes to be able to evaluate children earlier with stage I and II disease and to evaluate treatment response earlier so that the units can decide if a change in treatment is necessary, it is also hoped to provide an intensification of treatment for the stage IV disease.",[149],"Burkitt Lymphoma","2026-02-27",{"date":152,"type":153},"2026-03-02","ACTUAL",{"date":155,"type":153},"2020-11-01",{"date":157,"type":146},"2030-12-31",{"name":5,"class":6},7]